IRVINE, Calif., April 25, 2017 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended March 31, 2017.
Fi…
April 26, 2017 at 01:46AM
from
No comments:
Post a Comment